 |
|
Why the Slow Diffusion of Treatment Guidelines Into Clinical Practice?
Theodore A. Kotchen, MD
Arch Intern Med. 2007;167(22):2394-2395.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
From 1960 to 1994, the age-adjusted mortality rates for stroke and coronary heart disease declined by 60% and 53%, respectively. Cardiovascular mortality has continued to decline since 1994, although at a less steep rate. A number of factors have contributed to these favorable trends, including a better understanding of the risks of "benign" hypertension and the increased availability of effective antihypertensive agents. In clinical trials, antihypertensive therapy has been associated with 35% to 40% reductions in stroke incidence, 20% to 25% reductions in myocardial infarction, and more than a 50% reduction in the incidence of heart failure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure1 has recommended that, as target goals, blood pressure should be lower than 140/90 mm Hg for patients receiving antihypertensive therapy and lower than 130/80 mm Hg for patients with diabetes mellitus . . . [Full Text of this Article]
AUTHOR INFORMATION
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Inadequate Control of Hypertension in US Adults With Cardiovascular Disease Comorbidities in 2003-2004
Nathan D. Wong, Victor A. Lopez, Gilbert L'Italien, Roland Chen, Sue Ellen J. Kline, and Stanley S. Franklin
Arch Intern Med. 2007;167(22):2431-2436.
ABSTRACT
| FULL TEXT
|
